Ultrasound guided radiation therapy for intermediate risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise radiation treatment for men with intermediate risk prostate cancer. It uses a special ultrasound to guide the radiation, aiming to treat the cancer while protecting healthy tissue. You should consider this if you have not had prior prostate cancer treatment and meet the risk category.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer (confirmed by biopsy within the last year).
- Your cancer is classified as intermediate risk (your doctor can check this).
- You have a good performance status (able to do daily activities without help, specifically ECOG 0-1).
- You are willing to fill out quality of life questionnaires and give informed consent.
- You do not have a prostate larger than 60cc (measured by ultrasound).
- You have no history of earlier prostate cancer treatment or a transurethral resection of the prostate (TURP).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial studies a type of focused radiation (“ablative radiotherapy”) for prostate tumors considered intermediate- or high-risk. It may help improve control of the cancer while aiming for acceptable side effects.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.